Home\About Us\Members\ Biographical Sketch - Jean Rene Jourdain
Dr. Jean-Rene Jourdain

Dr. Jean-Rene Jourdain

Dr. Jean-Rene Jourdain serves as Deputy Director of International Affairs at the French Institute for Radiological Protection and Nuclear Safety (IRSN) since May 2017. He has previously held positions as radiopharmacist in several Parisian hospitals (1992-1999), pharmacist in charge of doping issues at the French Ministry of Youth and Sports (1999-2000), head of the IRSN's internal dose assessment and modelling laboratory (2000-2003), head of the IRSN's internal dosimetry department (2003-2008), representative of the IRSN's director of radiological protection in charge of international partnerships and cross-departmental activities (2008-2012), and deputy director of radiological protection and health at IRSN (2012-2017).

Dr. Jourdain received a PhD in radiobiology and radiopathology (1997), a doctorate in pharmacy (1996), and a master degree in health law (1994) from the University of Paris, France.

Dr. Jourdain was an expert of the European HLEG on low-dose risk research in 2008-2009 and was involved in several past EC-funded projects, e.g. DoReMi (WP leader, FP7, 2010-2015; project dealing among others with radiation-induced non-cancers effects) and OPERRA (Coordinator, FP7, 2013-2017; project on integration of European research in radiation protection). He is currently involved as a member of the Management and Executive Boards of the EC-funded CONCERT H2020 project (2015-2020; European Joint Programming Instrument in Radiation Protection Research), and as a work package leader within the EC-funded MEDIRAD H2020 project (2017-2021; project on the medical uses of ionizing radiation).

Other professional activities of Dr. Jourdain include being the Chairman of the Working Group on Nuclear and Radiological Threats within the Global Health Security Initiative bringing together Ministries and Secretaries of Health from G7 countries (2007-2014) and Chairman of an UNSCEAR expert group in charge of assessing doses and health effects in workers involved in the Fukushima Daiichi nuclear facilities.

Dr. Jourdain has been member of the French delegation since 2008 and has been the representative of France for the sixty-fourth session, 2017 and sixty-fifth sessions (2018).

Last updated: Wednesday, 14 October 2020